| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 247.053 | 259.624 | 277.346 | 309.398 | 227.567 | 0 | 7.562 | 3.849 | 2.144 | 1.026 |
| Total Income - EUR | 262.969 | 274.118 | 298.243 | 336.216 | 567.807 | 24.272 | 8.098 | 3.979 | 2.276 | 2.413 |
| Total Expenses - EUR | 265.490 | 268.817 | 293.564 | 326.393 | 282.463 | 43.017 | 15.059 | 7.960 | 6.149 | 5.395 |
| Gross Profit/Loss - EUR | -2.521 | 5.301 | 4.679 | 9.823 | 285.345 | -18.745 | -6.961 | -3.981 | -3.873 | -2.981 |
| Net Profit/Loss - EUR | -3.902 | 4.401 | 1.733 | 6.642 | 280.465 | -18.988 | -7.102 | -4.098 | -3.895 | -2.981 |
| Employees | 5 | 5 | 6 | 6 | 4 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Vlasimed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 10.142 | 5.653 | 14.795 | 11.073 | 7.730 | 3.271 | 1.501 | 1.422 | 1.158 | 1.125 |
| Current Assets | 218.283 | 138.925 | 150.834 | 165.516 | 273.566 | 30.102 | 40.700 | 36.454 | 33.439 | 30.628 |
| Inventories | 95.570 | 106.129 | 112.803 | 123.382 | 24.145 | -31 | 12.640 | 10.071 | 8.919 | 7.681 |
| Receivables | 14.842 | 9.982 | 28.332 | 38.047 | 1.032 | 26.079 | 23.688 | 23.755 | 23.845 | 22.518 |
| Cash | 40.203 | 22.608 | 9.699 | 4.087 | 248.390 | 4.054 | 4.371 | 2.627 | 675 | 429 |
| Shareholders Funds | 186.916 | 103.669 | 101.819 | 107.058 | 280.516 | 33.595 | 24.309 | 20.286 | 16.096 | 13.025 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 0 |
| Debts | 42.558 | 41.445 | 65.575 | 70.352 | 1.333 | 1.541 | 19.600 | 19.303 | 20.209 | 20.427 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4771 - 4771" | |||||||||
| CAEN Financial Year |
4771
|
|||||||||
Comments - Vlasimed Srl